7 About this resource
This resource accompanies NICE technology appraisal guidance on sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction. It was developed using the NICE adoption and impact programme: process guide for adoption support resources for health technologies. It is an implementation tool and discusses and summarises the experiences reported by NHS sites planning to adopt this technology and shares the learning that took place.
It is the responsibility of local commissioners and providers to implement the guidance at a local level, being mindful of their duty to advance equality of opportunity and foster good relations. Nothing in this document should be interpreted in a way that would be inconsistent with this.
Click here for more information about the adoption and impact programme.
Copyright
© National Institute for Health and Care Excellence 2016. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.
ISBN: 978-1-4731-2000-6